skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 22,249  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of hormonal therapies for prostate cancer on cognition: The ongoing search for clarity
Material Type:
Article
Add to My Research

Effect of hormonal therapies for prostate cancer on cognition: The ongoing search for clarity

Cancer, 2024-06, Vol.130 (12), p.2098-2100 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35283 ;PMID: 38491974

Digital Resources/Online E-Resources

2
The 340B Program and oral specialty drugs for advanced prostate cancer
Material Type:
Article
Add to My Research

The 340B Program and oral specialty drugs for advanced prostate cancer

Cancer, 2024-06, Vol.130 (12), p.2160-2168 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35262 ;PMID: 38395607

Digital Resources/Online E-Resources

3
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance
Material Type:
Article
Add to My Research

The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance

Cancer, 2024-06, Vol.130 (12), p.2108-2119 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35241 ;PMID: 38353455

Digital Resources/Online E-Resources

4
Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation
Material Type:
Article
Add to My Research

Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation

Cancer, 2024-06, Vol.130 (12), p.2205-2214 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35252 ;PMID: 38358333

Digital Resources/Online E-Resources

5
Post‐diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort study
Material Type:
Article
Add to My Research

Post‐diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort study

Cancer, 2024-06, Vol.130 (12), p.2169-2179 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35234 ;PMID: 38319287

Digital Resources/Online E-Resources

6
Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicenter retrospective study
Material Type:
Article
Add to My Research

Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicenter retrospective study

Cancer, 2024-06, Vol.130 (12), p.2139-2149 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35232 ;PMID: 38315517

Digital Resources/Online E-Resources

7
Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study
Material Type:
Article
Add to My Research

Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study

Cancer, 2024-06, Vol.130 (12), p.2224-2236 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35236 ;PMID: 38373075

Digital Resources/Online E-Resources

8
The association of metabolic syndrome score trajectory patterns with risk of all cancer types
Material Type:
Article
Add to My Research

The association of metabolic syndrome score trajectory patterns with risk of all cancer types

Cancer, 2024-06, Vol.130 (12), p.2150-2159 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35235 ;PMID: 38462898

Digital Resources/Online E-Resources

9
Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death‐1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105‐204)
Material Type:
Article
Add to My Research

Phase 1b/2 study of penpulimab (AK105), an antiprogrammed cell death‐1 immunoglobulin G1 antibody, in advanced or metastatic solid tumors (AK105‐204)

Cancer, 2024-06, Vol.130 (12), p.2180-2190 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35259 ;PMID: 38412283

Digital Resources/Online E-Resources

10
Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta‐analysis
Material Type:
Article
Add to My Research

Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta‐analysis

Cancer, 2024-06, Vol.130 (12), p.2120-2138 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35210 ;PMID: 38306301

Digital Resources/Online E-Resources

11
The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
Material Type:
Article
Add to My Research

The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study

Cancer, 2024-06, Vol.130 (12), p.2191-2204 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35247 ;PMID: 38376917

Digital Resources/Online E-Resources

12
Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma
Material Type:
Article
Add to My Research

Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma

Cancer, 2024-06, Vol.130 (12), p.2215-2223 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35256 ;PMID: 38376914

Digital Resources/Online E-Resources

13
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era
Material Type:
Article
Add to My Research

Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era

Cancer, 2024-06, Vol.130 (11), p.2031-2041 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35230 ;PMID: 38294959

Digital Resources/Online E-Resources

14
Physical activity and pain in people with and without cancer
Material Type:
Article
Add to My Research

Physical activity and pain in people with and without cancer

Cancer, 2024-06, Vol.130 (11), p.2042-2050 [Peer Reviewed Journal]

2024 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. ;2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35208 ;PMID: 38343307

Digital Resources/Online E-Resources

15
Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort
Material Type:
Article
Add to My Research

Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort

Cancer, 2024-06, Vol.130 (11), p.2060-2073 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35212 ;PMID: 38280205

Digital Resources/Online E-Resources

16
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome
Material Type:
Article
Add to My Research

Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome

Cancer, 2024-06, Vol.130 (11), p.1964-1971 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35251 ;PMID: 38340331

Digital Resources/Online E-Resources

17
Cancer Statistics 2024: Deaths drop, incidences increase, prevention needed
Material Type:
Article
Add to My Research

Cancer Statistics 2024: Deaths drop, incidences increase, prevention needed

Cancer, 2024-06, Vol.130 (11), p.1904-1904 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35347 ;PMID: 38757629

Digital Resources/Online E-Resources

18
Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study
Material Type:
Article
Add to My Research

Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study

Cancer, 2024-06, Vol.130 (11), p.1991-2002 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35226 ;PMID: 38404184

Digital Resources/Online E-Resources

19
A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer
Material Type:
Article
Add to My Research

A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer

Cancer, 2024-06, Vol.130 (11), p.1916-1929 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35285 ;PMID: 38529566

Digital Resources/Online E-Resources

20
Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt
Material Type:
Article
Add to My Research

Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt

Cancer, 2024-06, Vol.130 (11), p.1952-1963 [Peer Reviewed Journal]

2024 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.35214 ;PMID: 38244208

Digital Resources/Online E-Resources

Results 1 - 20 of 22,249  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1964  (112)
  2. 1964 To 1978  (3,321)
  3. 1979 To 1993  (7,508)
  4. 1994 To 2009  (7,066)
  5. After 2009  (4,263)
  6. More options open sub menu

Subject 

  1. Male  (22,213)
  2. Humans  (21,982)
  3. Oncology  (18,975)
  4. Life Sciences & Biomedicine  (18,567)
  5. Science & Technology  (18,567)
  6. Female  (17,012)
  7. Middle Aged  (15,038)
  8. Aged  (12,732)
  9. Adult  (12,584)
  10. Biological And Medical Sciences  (11,895)
  11. Medical Sciences  (11,879)
  12. Tumors  (6,366)
  13. Adolescent  (4,790)
  14. Prognosis  (4,735)
  15. Aged, 80 And Over  (3,926)
  16. Child  (3,318)
  17. Cancer Research  (2,900)
  18. Retrospective Studies  (2,448)
  19. Neoplasm Staging  (2,325)
  20. Follow-Up Studies  (2,255)
  21. More options open sub menu

Language 

  1. Japanese  (2,938)
  2. German  (27)
  3. Russian  (2)
  4. Norwegian  (2)
  5. More options open sub menu

Searching Remote Databases, Please Wait